Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection.
about
Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003C4d deposits on the surface of RBCs in trauma patients and interferes with their functionImmunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questionsMice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of toleranceAntibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.Complement activation in astrocytomas: deposition of C4d and patient outcomePhosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.B cells in cardiac transplants: from clinical questions to experimental modelsThe classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.Report from a consensus conference on antibody-mediated rejection in heart transplantationHLA class I antibody-mediated endothelial and smooth muscle cell activation.Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis.Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.Banff 07 classification of renal allograft pathology: updates and future directions.Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.Clearance of complement by human vascular endothelial cells: effects of hypoxia/reoxygenation and IL-1beta activation.The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
P2860
Q33829159-E7071256-48BC-499D-B76D-67BFA9AB0637Q33906277-9CE1BF39-0A9E-4C39-839F-C45B9FA3400EQ34289043-DE705188-DCBC-4213-89F3-5AA9C45A78BEQ34333956-8EFB9109-9DFD-4630-8D8D-044CE70E6AD9Q34342506-44E5581D-E872-446A-A779-DEE0584C7F82Q34496822-F1B41AFC-3099-4978-8B8C-B55408BBEDD1Q35469913-632D961C-0790-41E3-B389-D82D7CD277E4Q35691658-DD372066-75F3-4A7F-BD72-62313AA232DCQ35840324-A925632C-657D-4FDB-A9F9-1AAA0095FFB5Q36984472-B3601937-A019-4FB7-A5CC-1B5A449B8B12Q37313051-4E6C7139-F0BF-4474-95F5-94E1399247A4Q37430871-1892C56E-D66C-4A21-A058-F2120A91AF70Q38032621-A7BD3DC1-5DBB-4552-9EBA-5369C510AC15Q38145567-FC399F39-BCA2-4C93-AB42-18FAC97F3B09Q38440953-768A66A9-6ACD-456F-A938-ADC3608EFCC6Q38635500-D133125F-04C4-4FDA-B5D5-47E0239C27A4Q40121163-79AA2F96-2ED8-44BF-9B79-454614E7A824Q42138480-4F40DB80-7448-4EBC-9E36-76F65D30C080Q42424933-D5C77AB3-7038-46CB-9D50-AB34DA7748DEQ47831117-59007AFE-5C88-4D77-AB2C-0F3FCCDDE004Q48305003-C059717D-1666-4B88-97A6-26E5C6E239BEQ53227865-D526DDF0-1CC3-41FD-993A-B2D79483F9F6
P2860
Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@ast
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@en
type
label
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@ast
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@en
prefLabel
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@ast
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@en
P2093
P2860
P1476
Beyond C4d: other complement-r ...... o antibody-mediated rejection.
@en
P2093
Andrea A Zachary
Barbara A Wasowska
E Rene Rodriguez
Edward K Kasper
William M Baldwin
P2860
P304
P356
10.1111/J.1600-6143.2004.00348.X
P407
P577
2004-03-01T00:00:00Z